Assignee
RAFAEL PHARMACEUTICALS INC
US·8 granted patents·9 pending applications·13 citations·filing 2016–2021
Top patents by PatentIndex Score
17 records- 0186US10391177B2Methods for treating cancer using 6,8-bis (benzylthio) octanonic acidRAFAEL PHARMACEUTICALS INC·Filed 2018·Granted Aug 27, 2019·3 cites·44 claims
- 0285US10098955B2Pharmaceutical formulations containing lipoic acid derivativesRAFAEL PHARMACEUTICALS INC·Filed 2017·Granted Oct 16, 2018·3 cites·22 claims
- 0385US9872845B2Methods of treating myeloma and lymphoma using compositions containing an ion pair of a lipoic acid derivativeRAFAEL PHARMACEUTICALS INC·Filed 2016·Granted Jan 23, 2018·4 cites·20 claims
- 0477US11622950B2Therapeutic methods and compositions for treating pancreatic cancer using 6,8-bis-benzylthio-octanoic acidRAFAEL PHARMACEUTICALS INC·Filed 2019·Granted Apr 11, 2023·2 cites·10 claims
- 0576US11065335B2Methods of treating leukemia using compositions containing bis(benzylthio)octanoic acid and ion pairs thereofRAFAEL PHARMACEUTICALS INC·Filed 2019·Granted Jul 20, 2021·0 cites·4 claims
- 0671US10179796B2Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2017·Granted Jan 15, 2019·1 cites·24 claims
- 0764US2020331931A1Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0860US2018273551A1Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0956US2022184212A1Pharmaceutical formulations containing lipoic acid derivativesRAFAEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1055US10526357B2Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2018·Granted Jan 7, 2020·0 cites·18 claims
- 1153US2023348373A1Deuterated derivatives of 6,8-bis(benzylsulfanyl)octanoic acidRAFAEL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1249US2022040133A1Oral therapy using 6,8-bis-benzylthio-octanoic acidRAFAEL PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1347US2022054445A1Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitorRAFAEL PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1446US2021000778A1Therapeutic methods and compositions for treating prostate cancer using 6,8-bis-benzylthio-octanoic acidRAFAEL PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1544US10450337B2Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2017·Granted Oct 22, 2019·0 cites·25 claims
- 1640US2022151994A1Therapeutic methods and compositions for treating lymphoma using 6,8-bisbenzylthio-octanoic acidRAFAEL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1738US2021393664A1Therapeutic methods and compositions for treating acute myeloid leukemia using devimistatRAFAEL PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RAFAEL PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →